Fallopian Tube Removal and Ovarian Cancer Risk: What the Research Shows

For decades, ovarian cancer prevention understandably focused on the ovaries. Research has changed that conversation. Scientists now understand that many of the most common and lethal ovarian cancers begin not in the ovaries, but in the fallopian tubes.

A recent Becker’s Oncology Report article examines growing efforts to bring that discovery into clinical practice. Bram Goldstein, Ph.D., President and Senior Clinical Fellow of the Women’s Cancer Research Foundation, provides additional clinical context on fallopian tube removal and its potential role in reducing ovarian cancer risk.

A Clinical Perspective from Bram Goldstein, Ph.D. About Fallopian Tube Removal and Ovarian Cancer Risk

Nearly all fatal ovarian cancer tumors start as microscopic disease that spill from the fallopian tube to the ovary, where the cells spread and grow. However, the cancer cells are not always visualized on radiologic scans, confounding an early diagnosis.

Salpingectomy, involving the surgical removal of the fallopian tube, can be performed during most abdominal surgeries and prevents the malignant cells from spreading. A recent study published in JAMA Network Open indicated that a salpingectomy reduces the risk of developing ovarian cancer by nearly 80%.

Nevertheless, some oncologists are concerned that awareness of the prevention strategy has not transformed clinical care. The American Cancer Society, European Society of Gynaecological Oncology, and the American College of Surgeons currently endorse offering fallopian tube removal to patients while they are undergoing an abdominal surgery.

Why This Research Matters

Research changes care by changing what healthcare professionals know, what they discuss with patients, and what may be possible in cancer prevention. This study adds important evidence that removing the fallopian tubes during another planned surgery may significantly reduce the risk of certain ovarian cancers.

The next challenge is moving that knowledge from research into clinical practice. Greater awareness can lead to more informed conversations between patients and their healthcare professionals when the procedure may be relevant.

Whether fallopian tube removal is appropriate is an individual medical decision that should be discussed with a qualified healthcare professional.

Read the original article: Single Procedure Cuts Ovarian Cancer Risk by 80%: Report — Becker’s Oncology Report

Medical note: This article is intended for educational purposes only and does not provide medical advice or an individualized surgical recommendation. Please consult a qualified healthcare professional about personal cancer risk, reproductive considerations, and the potential risks and benefits of any procedure.